<DOC>
	<DOCNO>NCT01089738</DOCNO>
	<brief_summary>This study design look safety blood concentration PF-03382792 healthy elderly subject take multiple dos 14 day .</brief_summary>
	<brief_title>A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals</brief_title>
	<detailed_description>To examine safety , toleratibilty pharmacokinetics PF-03382792 healthy elderly subject .</detailed_description>
	<criteria>Healthy volunteer age 6580 year old Body Mass Index ( BMI ) 17.5 30.5 kg/m2 Total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Subjects symptoms sign adrenal insufficiency . Subjects clinically significant ocular lens abnormality detect investigator base finding slit lamp examination perform ophthalmologist .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>mulitple dose</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>healthy elderly volunteer</keyword>
</DOC>